MedTrace Logo

Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING

NCT02645968 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-12-07

No results posted yet for this study

Summary

The purpose of this study is to collect valid data from all forms of health care on the incidence, prevalence, the regional distribution, characteristics, management and outcomes of different ILDs under clinical practice conditions.

Conditions

  • Interstitial Lung Disease (ILD)

Sponsors & Collaborators

  • University of Giessen

    collaborator OTHER

  • German Center for Lung Research

    collaborator OTHER

  • Helmholtz Zentrum München

    collaborator INDUSTRY

  • Institut für Lungenforschung e.V.

    collaborator UNKNOWN

  • German Respiratory Society

    collaborator OTHER

  • WATL e.V.

    collaborator UNKNOWN

  • Bundesverband der Pneumologen

    collaborator UNKNOWN

  • Lungenfibrose e.V.

    collaborator UNKNOWN

  • Sacura GmbH

    collaborator OTHER

  • Syneed Medidata GmbH

    collaborator INDUSTRY

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Michael Kreuter, Prof. Dr. · Centre for interstitial and rare lung diseases, Pneumology and Respiratory Medicine, Thorax Clinic, University Hospital Heidelberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2020-04-30
Completion
2020-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02645968 on ClinicalTrials.gov